DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

0.00 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CADX $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio -49.93
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $0.13

Sector

Healthcare

Industry

Drugs

Cadence Pharmaceuticals, Inc. (CADX) Description

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. Website: http://www.cadencepharm.com/

News & Commentary

Can Malllinckrodt Keep on Crushing Expectations?

FDA Approves Mallinckrodt's Xartemis XR - Analyst Blog

Recro Pharma IPO Could Be More Painful Than Expected

Wider-Than-Expected Q4 Loss at Cadence Pharma - Analyst Blog

Wider-Than-Expected Q4 Loss at Cadence Pharma - Analyst Blog

Patent Update from Mallinckrodt - Analyst Blog

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog

This Week in Biotech: Three Strikes and You're Out!

The FDA and its advisory panel give a thumbs down to three experimental drugs, while buyout mania strikes the biotech sector.

Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment

Everyone Wins in This Big Pharma Buyout

Here's one pharmaceutical buyout that the market loved on all sides.

Cadence Soars on Deal with Mallinckrodt - Analyst Blog

See More CADX News...

CADX's Top Competitors

CADX $0.00 (0.00%)
Current stock: CADX
JNJ $100.22 (0.04%)
Current stock: JNJ
NVS $86.17 (-0.45%)
Current stock: NVS
RHHBY $36.22 (-0.14%)
Current stock: RHHBY